Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy

AIMS: This open‐label prospective phase I/IIa clinical study used autologous bone marrow‐derived mesenchymal stromal cells (BM‐MSCs) followed by mesenchymal stromal cells conditioned media (MSC‐CM) for the first time to treat multiple sclerosis (MS) patients. The primary goal was to assess the safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahbour, Said, Jamali, Fatima, Alhattab, Dana, Al‐Radaideh, Ali, Ababneh, Osama, Al‐Ryalat, Nosaiba, Al‐Bdour, Muawyeh, Hourani, Bayan, Msallam, Mohammed, Rasheed, Murad, Huneiti, Ammar, Bahou, Yacoub, Tarawneh, Emad, Awidi, Abdalla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698713/
https://www.ncbi.nlm.nih.gov/pubmed/28961381
http://dx.doi.org/10.1111/cns.12759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698713/
https://www.ncbi.nlm.nih.gov/pubmed/28961381
http://dx.doi.org/10.1111/cns.12759

Ejemplares similares